Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic versus therapeutic perioperative amiodarone in cardiac surgery patients at risk of atrial fibrillation
IRCT20120215009014N392Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Incidence of atrial fibrillation. Started Jun 2021; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20120215009014N392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N392.